SCOPUS 정보 검색 플랫폼

Journal of Medical Economics

Volumn 4, Issue 127-135, 2001, Pages 127-135

Cost-effectiveness of oxaliplatin in combination with 5-FU/FA compared with 5-FU/FA alone

(5) Nicholls, C J a Cassidy, J a Freemantle, N a Harrison, M a Carita, P a

a SANOFI (France)

Author keywords

5 fluorouracil; Advanced colorectal cancer; Chemotherapy; Cost effectiveness; Oxaliplatin; Progression free year

Indexed keywords

FLUOROURACIL; FOLINIC ACID; OXALIPLATIN;

ADVANCED CANCER; ARTICLE; CANCER GROWTH; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL TRIAL; COLORECTAL CANCER; COST EFFECTIVENESS ANALYSIS; DRUG COST; HOSPITAL COST; HUMAN; INTERMETHOD COMPARISON; PHASE 3 CLINICAL TRIAL; TREATMENT OUTCOME; UNITED KINGDOM;

EID: 0034780871 PISSN: 13696998 EISSN: None Source Type: Journal
DOI: 10.3111/200104127135 Document Type: Article

Times cited : (6)

References (21)

1
- 0003722925
- (1999) Cancer Research Campaign Factsheet

2
- 0003940339
- London: NHS Executive, Department of Health
- (1997) Improving outcomes in colorectal cancer: the manual

3
- 0030881538
- Attitudes and practice in the management of metastatic colorectal cancer in Britain
- Colorectal Cancer Working Party of the UK Medical Research Council
- (1997) Clinical Oncology , vol.9 , pp. 248-251
- Seymour, M.T.¹ Stenning, S.P.² Cassidy, J.³

4
- 0027379619
- The chemotherapy of colon cancer can no longer be ignored
- (1993) European Journal of Cancer , vol.29 A , pp. 2077-2079
- Cunningham, D.¹ Findlay, M.²

5
- 0030463987
- Factors influencing response rates for advanced colorectal cancer chemotherapy
- (1996) Annals of Oncology , vol.7 , pp. 901-906
- Labianca, R.¹ Pancera, G.² Luporini, G.³

6
- 0033874892
- Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer
- (2000) Journal of Clinical Oncology , vol.18 , pp. 2938-2947
- De Gramont, A.¹ Figer, A.² Seymour, M.³

7
- 0033989203
- Phase III multicenter randomized trial of oxaliplatin added to chronomodulated fluorouracil-leucovorin as first-line treatment of metastatic colorectal cancer
- (2000) Journal of Clinical Oncology , vol.18 , pp. 136-147
- Giacchetti, S.¹ Perpoint, B.² Zidani, R.³

8
- 0028036652
- Chronomodulated versus fixed-infusion-rate delivery of ambulatory chemotherapy with oxaliplatin, fluorouracil, and folinic acid (leucovorin) in patients with colorectal cancer metastases: A randomized multi-institutional trial
- (1994) Journal of the National Cancer Institute , vol.86 , pp. 1608-1617
- Levi, F.A.¹ Zidani, R.² Vannetzel, J.M.³

9
- 0026512446
- A chronopharmacologic phase II clinical trial with 5-fluorouracil, folinic acid, and oxaliplatin using an ambulatory multichannel programmable pump. High antitumor effectiveness against metastatic colorectal cancer
- (1992) Cancer , vol.69 , pp. 893-900
- Levi, F.¹ Misset, J.L.² Brienza, S.³

10
- 0039276846
- A multicenter evaluation of intensified, ambulatory, chronomodulated chemotherapy with oxaliplatin, 5-fluorouracil, and leucovorin as initial treatment of patients with metastatic colorectal carcinoma
- International Organization for Cancer Chronotherapy
- (1999) Cancer , vol.85 , pp. 2532-2540
- Levi, F.¹ Zidani, R.² Brienza, S.³

11
- 33845382806
- Nonparametric estimation from incomplete observations
- (1958) Journal of the American Statistics Association , vol.53 , pp. 457-481
- Kaplan, E.¹ Meier, P.²

12
- 0031019918
- Randomized trial comparing monthly low-dose leucovorin and fluorouracil bolus with bimonthly high-dose leucovorin and fluorouracil bolus plus continuous infusion for advanced colorectal cancer: A French intergroup study
- (1997) Journal of Clinical Oncology , vol.15 , pp. 808-815
- De Gramont, A.¹ Bosset, J.F.² Milan, C.³

13
- 0004089921
- London: Haymarket Medical Ltd
- (2000) Monthly Index of Medical Specialities. September edn.

14
- 0004223602
- London: British Medical Association and the Royal Pharmaceutical Society of Great Britain
- (2000) British National Formulary. March 2000 edn.

15
- 0003462471
- Personal Social Services Research Unit, University of Kent
- (1999) Unit costs of health and social care
- Netten, A.¹ Dennett, J.² Knight, J.³

16
- 0012176070
- London, Department of Health
- (1998) NHS Reference Costs

17
- 0003036420
- (1999)

18
- 0002895894
- (2000) The Royal Marsden Drug and Therapeutics Advisory Committee Prescribing Guidelines

19
- 0003998061
- Cancer
- Philadelphia: Lippincott-Raven
- (1997) Principals and practice of oncology. 5th edn.
- Devita V.T., Jr.¹ Hellman, S.² Rosenberg, S.A.³

20
- 0003760756
- York: NHS Centre for Reviews and Dissemination
- (2000) A systematic review of the effectiveness and cost-effectiveness of the taxanes used in the treatment of advanced breast and ovarian cancer
- Lister-Sharp, D.¹ McDonagh, M.² Saeed Khan, K.³

21
- 0003037532
- Guidance on the use of orlistat for the treatment of obesity in adults
- (2001) Technology appraisal guidance No. 22

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.